The following is the list of 20 stocks that were recommended by Forbes India in their recent release
Page Industries: A small company that makes a small product with big margins
Pidilite Industries: Pidilite has brands like Fevicol, M-Seal, car polish Motomax and other assorted consumer art materials and specialised home paints
Dabur: This company has focus. Five years ago, Dabur got out of the pharmaceutical business and put all its effort, like the best brand companies, behind five of its brands
Procter and Gamble Hygiene: Over the last three years, the money that P&G invested did not translate into market cap gains
Marico: Till 2008-09 came by, the company’s sales and profits had grown for 30 consecutive quarters, indicating a stable track record
Blue Star: Two decades to reach Rs. 1,000 crore in sales; two years to reach Rs. 2,000 crore in 2008
For the rest check out this post
Filed under: investing | Tagged: best buys, emerging markets, indian stock markets, indian stocks, investing, money, stock picks, stocks, trading
India Top Stock Picks
http://www.fourstocks.com/
FourStocks.com allows users to compare their BSE/NSE equity picks with other members and street analysts. Its unique stock rating system provides a goldmine of investment ideas. The site also provides extensive financial information and gives a 3-dimensional view of companies and markets.
Find Top Ten Stocks
http://www.fourstocks.com/stocks
FourStocks.com allows users to compare their BSE/NSE equity picks with other members and street analysts. Its unique stock rating system provides a goldmine of investment ideas. The site also provides extensive financial information and gives a 3-dimensional view of companies and markets.
Stock Picks
http://www.fourstocks.com/
FourStocks.com allows users to compare their BSE/NSE equity picks with other members and street analysts. Its unique stock rating system provides a goldmine of investment ideas. The site also provides extensive financial information and gives a 3-dimensional view of companies and markets.
My stock pick is Mentor Capital (MNTR). They will be increasing their already 20% interest in a privately held bio-tech company as they continue to fund their immunotherapy breast cancer treatment, which is safer and has milder side effects than existing treatments. I am optimistic of the effect this will have on the value of Mentor Capital stock.